logo
搜索
菜单

FDA的搜索结果

当前1/2页
排序: 本月浏览数
An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis 10.3791/62838-v 09:34 min
An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
Retinal Vascular Reactivity as Assessed by Optical Coherence Tomography Angiography 10.3791/60948-v 07:23 min
Retinal Vascular Reactivity as Assessed by Optical Coherence Tomography Angiography
Assessment of Oxidative Damage in the Primary Mouse Ocular Surface Cells/Stem Cells in Response to Ultraviolet-C (UV-C) Damage 10.3791/59924-v 12:59 min
Assessment of Oxidative Damage in the Primary Mouse Ocular Surface Cells/Stem Cells in Response to Ultraviolet-C (UV-C) Damage
Shootward Movement of CFDA Tracer Loaded in the Bottom Sink Tissues of Arabidopsis 10.3791/59606-v 07:00 min
Shootward Movement of CFDA Tracer Loaded in the Bottom Sink Tissues of Arabidopsis
1.2: Preclinical Development: Overview 01:28 min
1.2: Preclinical Development: Overview
The NeuroStar TMS Device: Conducting the FDA Approved Protocol for Treatment of Depression 10.3791/2345-v
The NeuroStar TMS Device: Conducting the FDA Approved Protocol for Treatment of Depression
Evaluation of Cardiac Contractility Modulation Therapy in 2D Human Stem Cell-Derived Cardiomyocytes 10.3791/64848-v
Evaluation of Cardiac Contractility Modulation Therapy in 2D Human Stem Cell-Derived Cardiomyocytes
The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma 10.3791/58937-v
The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma
Simultaneous Study of the Recruitment of Monocyte Subpopulations Under Flow In Vitro 10.3791/58509-v 09:16 min
Simultaneous Study of the Recruitment of Monocyte Subpopulations Under Flow In Vitro
Magnetic-Activated Cell Sorting Strategies to Isolate and Purify Synovial Fluid-Derived Mesenchymal Stem Cells from a Rabbit Model 10.3791/57466-v 10:20 min
Magnetic-Activated Cell Sorting Strategies to Isolate and Purify Synovial Fluid-Derived Mesenchymal Stem Cells from a Rabbit Model
Assessing Lysosomal Alkalinization in the Intestine of Live Caenorhabditis elegans 10.3791/57414-v 06:18 min
Assessing Lysosomal Alkalinization in the Intestine of Live Caenorhabditis elegans
An Additive Manufacturing Technique for the Facile and Rapid Fabrication of Hydrogel-based Micromachines with Magnetically Responsive Components 10.3791/56727-v
An Additive Manufacturing Technique for the Facile and Rapid Fabrication of Hydrogel-based Micromachines with Magnetically Responsive Components
Cellular Redox Profiling Using High-content Microscopy 10.3791/55449-v 11:37 min
Cellular Redox Profiling Using High-content Microscopy
Modified MicroSecure Vitrification: A Safe, Simple and Highly Effective Cryopreservation Procedure for Human Blastocysts 10.3791/54871-v
Modified MicroSecure Vitrification: A Safe, Simple and Highly Effective Cryopreservation Procedure for Human Blastocysts
Measuring Protein Stability in Living Zebrafish Embryos Using Fluorescence Decay After Photoconversion (FDAP) 10.3791/52266-v 09:45 min
Measuring Protein Stability in Living Zebrafish Embryos Using Fluorescence Decay After Photoconversion (FDAP)
Generation of Recombinant Arenavirus for Vaccine Development in FDA-Approved Vero Cells 10.3791/50662-v 10:03 min
Generation of Recombinant Arenavirus for Vaccine Development in FDA-Approved Vero Cells
Surgical Technique for Spinal Cord Delivery of Therapies: Demonstration of Procedure in Gottingen Minipigs 10.3791/4371-v 09:23 min
Surgical Technique for Spinal Cord Delivery of Therapies: Demonstration of Procedure in Gottingen Minipigs
15.16: Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions 01:15 min
15.16: Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
11.7: FDA Approved Drugs: Changes to Approved Drugs 01:26 min
11.7: FDA Approved Drugs: Changes to Approved Drugs
11.4: Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence 01:27 min
11.4: Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence
返回顶部